On the other hand, in multi-hit TP53, mutations in FLT3 (both TKD and ITD) and partial tandem duplication of KMT2A have been identified as predictors of adverse outcomes and an increased risk of transformation into AML [39]. This evidence concerns the gene TP53 and acute myeloid leukemia.